Accelerate your product approvals with expert regulatory strategy, compliant dossier preparation, and end-to-end submission support — for pharmaceuticals, medical devices, and cosmetics across India and global markets.
At Medwisdom Lifescience, we combine deep regulatory expertise with strategic insight to simplify your path to market authorization. Our team includes ex-FDA managers, NDA application reviewers, and seasoned industry veterans — delivering transparent, efficient, and results-driven regulatory solutions.
We specialize in CTD, ACTD, and eCTD dossier preparation for product registration in full compliance with global standards — helping both innovator brands and generic drug manufacturers navigate complex regulatory pathways with confidence.
Our pharma regulatory affairs services cover key FDA submissions including:
We deliver more than compliance — we deliver competitive advantage through faster approvals, lower risk, and end-to-end regulatory lifecycle management.
Our consultants possess in-depth knowledge across pre-clinical studies, CMC, and clinical trial regulatory requirements for biologics, small molecules, vaccines, and ATMPs including gene therapy.
Unmatched expertise in Drugs & Cosmetics Act 1940, Drugs Rules 2020, and Medical Device Rules 2017 — with native language proficiency and authorized agent status for seamless CDSCO submissions.
Strategic regulatory alignment across FDA (USA), EMA (Europe), SFDA (Saudi Arabia), TGA (Australia) and 40+ international regulatory frameworks to accelerate your global expansion.
From early development strategy through to post-approval changes, pharmacovigilance, and product renewals — we support your product at every stage of its regulatory lifecycle.
Our proven processes, pre-submission meeting strategies, and proactive query resolution help minimize delays and keep your project on schedule and on budget.
Every client is assigned a dedicated regulatory project manager who provides regular updates, milestone tracking, and direct communication — no handoffs, no confusion.
Comprehensive regulatory support across pharmaceuticals, medical devices, and cosmetics — tailored to your product and market requirements.
Comprehensive end-to-end regulatory support for pharmaceutical product registration and ongoing compliance in India and international markets. From strategy to submission — we manage the full regulatory journey.
Full-spectrum regulatory assistance for medical device licensing, registration, and compliance management through CDSCO, Sugam Portal, and NSWS — for all device classes from Class A to Class D.
Complete regulatory and compliance support for cosmetic product import, domestic manufacturing, and post-market surveillance in India — fully aligned with the Cosmetics Rules 2020.
Combining specialized therapeutic knowledge with comprehensive Indian and global regulatory frameworks to deliver commercially valuable outcomes.
Our experienced team provides regulatory support across the full spectrum of therapeutic categories — from early pre-clinical through to Phase III clinical trials and market authorization.
Medwisdom Lifescience is a trusted authority in Indian regulatory affairs with deep statutory knowledge, enabling accurate, efficient, and compliant submissions across all regulated categories.
Proven expertise across major international regulatory frameworks — enabling seamless multi-market submissions and simultaneous approval strategies to reduce time-to-market globally.
We offer complete post-approval lifecycle support — from managing variations and renewals to pharmacovigilance obligations, audit preparation, and compliance maintenance programs.
A structured, transparent, milestone-driven approach that keeps your project on time and compliant at every stage.
We conduct a comprehensive review of your product, target markets, and existing documentation to identify regulatory gaps and define the optimal pathway to approval.
A bespoke regulatory strategy is developed — covering submission timelines, authority interactions, dossier structure, and risk mitigation to maximize approval probability.
Our expert team prepares, compiles, and quality-reviews CTD/eCTD/ACTD dossiers ensuring technical accuracy and full alignment with authority requirements.
We manage the submission process end-to-end — electronic or paper — including pre-submission meetings, query responses, and authority follow-ups.
After approval, we support variations, renewals, label updates, pharmacovigilance reporting, GxP audits, and ongoing compliance maintenance to sustain market access.
From India to North America, Europe, Middle East, Africa, and ASEAN — we have the expertise to support your international market access strategy.
Not seeing your target market? Contact us — we cover 40+ countries worldwide.
Trusted by pharmaceutical companies, medical device manufacturers, and cosmetic brands across India and globally.
"Medwisdom's team navigated our CDSCO medical device registration with exceptional precision. Their end-to-end support helped us launch 3 months ahead of schedule."
"Their eCTD dossier preparation for our EU submission was thorough and compliant. The team's knowledge of EMA requirements gave us real confidence in our submission."
"We've worked with many regulatory consultants, but Medwisdom stands apart for their transparency and speed. Our ANDA was approved with zero deficiencies on the first cycle."
Everything you need to know about our pharma regulatory affairs consulting services.
Speak with India's leading pharma regulatory affairs consultants — free, no-obligation consultation for your product.
